Related Experiment Video
Updated: Jan 19, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Small molecular target-based multifunctional upconversion nanocomposites for targeted and in-depth photodynamic and
Xiao Jia1, Huan-Nian Ye1, Huilan Weng2
1College of Chemistry, Institution Fujian Engineering Research Center for Drug and Diagnoses-Treatment of Photodynamic Therapy, State Key Laboratory of Photocatalysis on Energy and Environment, Fuzhou University, Fuzhou, China.
Abstract:
A novel multifunctional nano-system, ZnPc-UCNPs-PEG-G, was designed for targeted and in-depth photodynamic therapy. The nano-system was built via covalent conjugation, in which phthalocyanine zinc (ZnPc), Gefitinib (G), NaYF4: Yb, Er (UCNPs) and PEG derivatives were employed as the photosensitizer, target moiety, upconversion nanomaterial and linker unit, respectively. The photophysical/chemical properties, in-depth photodynamic activity, cancer cell specificity and anticancer activity of ZnPc-UCNPs-PEG-G were investigated. The as-prepared ZnPc-UCNPs-PEG-G exhibits excellent photosensitizing ability, generating reactive oxygen species (ROS) via effective energy transfer from UCNP to phthalocyanine zinc. In addition, the composite exhibits specific affinity to HepG2 cancer cells and high anticancer activity. To the best of our knowledge, this is the only example of a UCNP platform that is capable of molecular targeted and in-depth photodynamic and chemo-anticancer therapy via the introduction of a small molecular targeting drug moiety.
Related Concept Videos
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
07:24Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal
Targeted Cancer Therapies
There are several types of targeted therapies against...
04:53An In Vitro Approach to Photodynamic Therapy
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
09:45Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

